Alirocumab efficiently reduces LP(A) levels by lowering Apolipoprotein (A) [APO(A)] production rate in Non-Human primates (NHP) - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement
Communication Dans Un Congrès Année : 2017

Alirocumab efficiently reduces LP(A) levels by lowering Apolipoprotein (A) [APO(A)] production rate in Non-Human primates (NHP)

Fichier non déposé

Dates et versions

hal-02737438 , version 1 (02-06-2020)

Identifiants

  • HAL Id : hal-02737438 , version 1
  • PRODINRA : 410674
  • WOS : 000407634000077

Citer

Mickael Croyal, - Thi-Thu-Trang Tran, Rose-Helene Blanchard, Jean-Chistophe Le Bail, Elise Villard, et al.. Alirocumab efficiently reduces LP(A) levels by lowering Apolipoprotein (A) [APO(A)] production rate in Non-Human primates (NHP). 85th Congress of the European-Atherosclerosis-Society (EAS), European Atherosclerosis Society. SWE., Apr 2017, Prague, Czech Republic. pp.1. ⟨hal-02737438⟩
28 Consultations
0 Téléchargements

Partager

More